NGeneBio Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	5,544	19,275	24,897	16,296
Short-Term Investments	151.59	129.05	10,021	8,011
Trading Asset Securities	-	3,023	-	-
Cash & Short-Term Investments	5,696	22,427	34,918	24,307
Cash Growth	-78.08%	-35.77%	43.66%	-
Accounts Receivable	1,546	788.95	1,125	1,574
Other Receivables	2,050	228.92	51.09	58.06
Receivables	3,596	1,018	1,176	1,632
Inventory	1,922	1,695	2,968	1,219
Prepaid Expenses	94.77	103.34	141.72	79.67
Other Current Assets	667.21	1,779	3,868	136.73
Total Current Assets	11,975	27,021	43,072	27,374
Property, Plant & Equipment	12,398	9,343	8,684	8,092
Long-Term Investments	1,364	2,837	1,378	5,451
Goodwill	5,804	416.32	416.32	416.32
Other Intangible Assets	1,356	1,456	1,224	1,247
Other Long-Term Assets	816.28	1,208	1,389	1,287
Total Assets	33,714	42,282	56,164	43,867
Accounts Payable	41.33	162.75	69.18	172.85
Accrued Expenses	335.39	253.59	235.99	188.37
Short-Term Debt	10,758	11,056	10,786	6,100
Current Portion of Long-Term Debt	-	-	-	362
Current Portion of Leases	1,053	241.11	295.95	161.89
Current Unearned Revenue	-	0	20.17	18.33
Other Current Liabilities	8,777	12,103	17,594	1,051
Total Current Liabilities	20,964	23,816	29,001	8,055
Long-Term Debt	-	-	-	500
Long-Term Leases	1,286	146.88	374.62	82.69
Other Long-Term Liabilities	150.56	150.52	165.38	43.69
Total Liabilities	24,079	26,048	30,837	9,869
Common Stock	12,889	12,889	12,526	12,431
Additional Paid-In Capital	55,200	55,102	52,570	51,982
Retained Earnings	-63,584	-53,941	-40,886	-31,381
Comprehensive Income & Other	4,188	2,244	1,086	965.73
Total Common Equity	8,694	16,295	25,297	33,998
Minority Interest	941.78	-60.68	30.24	-
Shareholders' Equity	9,635	16,234	25,327	33,998
Total Liabilities & Equity	33,714	42,282	56,164	43,867
Total Debt	13,097	11,444	11,456	7,207
Net Cash (Debt)	-7,402	10,983	23,462	17,100
Net Cash Growth	-	-53.19%	37.20%	-
Net Cash Per Share	-574.23	865.85	1880.24	1382.64
Filing Date Shares Outstanding	12.89	12.89	12.53	12.43
Total Common Shares Outstanding	12.89	12.89	12.53	12.43
Working Capital	-8,989	3,205	14,072	19,319
Book Value Per Share	674.49	1264.22	2019.58	2734.94
Tangible Book Value	1,533	14,422	23,656	32,334
Tangible Book Value Per Share	118.94	1118.95	1888.61	2601.11
Land	2,696	2,696	2,584	2,584
Buildings	4,044	4,044	3,040	3,040
Machinery	8,135	4,962	4,569	3,699
Construction In Progress	-	-	9.23	-

Source: S&P Capital IQ. Standard template. Financial Sources.